Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/30/2024
HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...
8/30/2024
NMPA Suspends Import, Sales and Use of Dr. Reddy's Atomoxetine Hcl Cap...
8/30/2024
Recent Executive Moves
8/30/2024
Regional Price Differences of Medical Services: Evidence from China (B...
8/29/2024
CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
8/28/2024
Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...
8/27/2024
NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
8/27/2024
BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
8/27/2024
Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab
8/27/2024
China Proposed New Anti-Monopoly Guidelines for the Pharmaceutical Sec...
8/26/2024
UCB Sells Chinese Neurology and Allergy Business for $680M
8/26/2024
CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
8/26/2024
China Issues the Notice on Facilitating the BMI for Urban and Rural Re...
8/26/2024
China Escalates Crackdown on Medical Insurance Frauds
8/26/2024
Over 70% of Village Clinics Now Covered by the BMI System
8/23/2024
Recent Executive Moves
8/22/2024
Everest Medicines Announces Initiation of Clinical Trial for Personali...
8/22/2024
China Further Opens Telecom, Education, and Healthcare Sectors to Fore...
8/22/2024
What Drives China's Healthcare Expenditure? A Theoretical and Empirica...
8/20/2024
Taking Stock of U.S.-China Biotechnology Competition (Asia Society)
8/20/2024
Merck Adjusts ADC Partnership with Kelun-Biotech, Takes Up One Option ...
8/20/2024
Adcendo Enters $1B Biobuck Deal for Multitude's Anti-TF ADC
8/20/2024
U.S. Lawmakers Call on the FDA to Investigate Clinical Trials Conducte...
8/20/2024
AstraZeneca Gains Chinese Approval of New Asthma Drug
8/19/2024
Astellas Secures Chinese Approval of Nectin-4 ADC Drug
8/19/2024
NMPA Restores Import, Sales and Use of UCB's Keppra
8/19/2024
Germany Warns of Potential Drug Shortages Due to China's Espionage Law
8/19/2024
FDA Lifts Partial Hold on BioNTech-MediLink ADC Study
Page:
20
/
354
Total number of articles:
10618
:
[First]
[<<]
[18]
[19]
[20]
[21]
[22]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit